Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 22, 2020
Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosisGabriela R Oates, Elizabeth Baker, Steven M Rowe, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 20, 2024
Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL)Elizabeth Baker, William T Harris, Jennifer S Guimbellot, et al.
Ethnicity & Health|September 30, 2016
Disparities in chronic medical conditions in the Mid-SouthBradford E Jackson, Gabriela R Oates, Karan P Singh, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 21, 2023
Mobile health platform for self-management of pediatric cystic fibrosis: Impact on patient-centered care outcomesGabriela R Oates, Cathy Mims, Robin Geurs, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 20, 2021
Cessation of smoke exposure improves pediatric CF outcomes: Longitudinal analysis of CF Foundation Patient Registry dataGabriela R Oates, Elizabeth Baker, Joseph M Collaco, et al.
Sleep Medicine|June 13, 2022
The association between sleep disturbances and neurocognitive function in pediatric sickle cell diseaseTiffany Tucker, Ammar Saadoon Alishlash, Jeffrey D Lebensburger, et al.
The Journal of Urology|April 27, 2021
Disparities in Kidney Stone Disease: A Scoping ReviewJoseph J Crivelli, Naim M Maalouf, Henry J Paiste, et al.
COPD|October 12, 2017
Social Determinants of Adherence to Pulmonary Rehabilitation for Chronic Obstructive Pulmonary DiseaseGabriela R Oates, Bryant W Hamby, Irena Stepanikova, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 29, 2026
Clinical effort against smoke exposure in cystic fibrosis (CEASE-CF): feasibility, acceptability, and preliminary efficacyGabriela R Oates, Robin Geurs, Cathy Mims, et al.
Pageof 8